Physician profile
Auston H Gray
NPI 1477526366
$1,589.96
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $528 · 2021: $585.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $444.57 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $250.71 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $212.07 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $124.84 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.90 | 2021 | |
| Adlon Therapeutics L.P. | $87.86 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $80.48 | 2021 | |
| Ironshore Pharmaceuticals INC. | $65.45 | 2019-2020 | |
| Neuronetics, INC. | $58.69 | 2019-2020 | |
| Allergan, INC. | $52.71 | 2020 | |
| Supernus Pharmaceuticals, INC. | $32.12 | 2021 | |
| Lundbeck LLC | $27.11 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $24.33 | 2019 | |
| Eisai INC. | $19.37 | 2021 | |
| Vanda Pharmaceuticals INC. | $17.75 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Auston Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.